Home NDC 24338-122 ERY-TAB
Product NDC 24338-122
11-digit product format 243380122
Labeler code 24338
Product ID 24338-122_f7f33758-f601-4397-baa4-30286a9a3a39
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Erythromycin
Dosage form TABLET, DELAYED RELEASE
Route ORAL
Labeler Arbor Pharmaceuticals, Inc.
Application ANDA062298
Marketing category ANDA
Marketing start 2011-04-18
Substance ERYTHROMYCIN
Active strength 250 mg/1
Pharmacologic classes Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062298-001 ERY-TAB ERYTHROMYCIN 250MG TABLET, DELAYED RELEASE / ORAL AB Approved before 1982 A062298-002 ERY-TAB ERYTHROMYCIN 500MG TABLET, DELAYED RELEASE / ORAL AB RS, Approved before 1982 A062298-003 ERY-TAB ERYTHROMYCIN 333MG TABLET, DELAYED RELEASE / ORAL AB 1982-03-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A062298-001 ERY-TAB 250MG TABLET, DELAYED RELEASE / ORAL AB Approved before 1982 a50c72e98297…2026-08-01 22:54:32 2026-06 A062298-002 ERY-TAB 500MG TABLET, DELAYED RELEASE / ORAL AB RS, Approved before 1982 a50c72e98297…2026-08-01 22:54:32 2026-06 A062298-003 ERY-TAB 333MG TABLET, DELAYED RELEASE / ORAL AB 1982-03-29 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base ERY-TAB
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ERYTHROMYCIN 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 63937KV33D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 206075 Internal RxNorm lookup 206078 Internal RxNorm lookup 206080 Internal RxNorm lookup 310155 Internal RxNorm lookup 310157 Internal RxNorm lookup 315090 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 24338-122-03 ERY-TAB 30 in 1 BOTTLE TABLET, DELAYED RELEASE 30 10 24338-122-13 ERY-TAB 100 in 1 BOTTLE TABLET, DELAYED RELEASE 100 10
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Erythromycin ACTIVE INGREDIENT 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 Erythromycin ACTIVE MOIETY 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 Ammonia INACTIVE INGREDIENT 5138Q19F1X ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 croscarmellose sodium INACTIVE INGREDIENT M28OL1HH48 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 crospovidone INACTIVE INGREDIENT 68401960MK ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 diacetylated monoglycerides INACTIVE INGREDIENT 5Z17386USF ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 hydroxypropyl cellulose (type H) INACTIVE INGREDIENT RFW2ET671P ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 hypromellose phthalate (24% PHTHALATE, 55 CST) INACTIVE INGREDIENT 87Y6436BKR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 magnesium stearate INACTIVE INGREDIENT 70097M6I30 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 povidones INACTIVE INGREDIENT FZ989GH94E ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 propylene glycol INACTIVE INGREDIENT 6DC9Q167V3 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 sodium citrate INACTIVE INGREDIENT 1Q73Q2JULR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 sorbitan monooleate INACTIVE INGREDIENT 06XEA2VD56 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 talc INACTIVE INGREDIENT 7SEV7J4R1U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 7 Erythromycin ACTIVE INGREDIENT 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 Erythromycin ACTIVE MOIETY 63937KV33D ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 AMMONIA INACTIVE INGREDIENT 5138Q19F1X ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 DIACETYLATED MONOGLYCERIDES INACTIVE INGREDIENT 5Z17386USF ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) INACTIVE INGREDIENT 87Y6436BKR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 POVIDONES INACTIVE INGREDIENT FZ989GH94E ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 SODIUM CITRATE INACTIVE INGREDIENT 1Q73Q2JULR ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 SORBITAN MONOOLEATE INACTIVE INGREDIENT 06XEA2VD56 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [CARILION MATERIALS MANAGEMENT] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 24338-122 ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [ARBOR PHARMACEUTICALS, INC.] 10 Current NDC, Legacy NDC, 2 package rows 20181212_fda44eb6-7901-4b80-ba0b-216f6cacf3fd.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 24338-122-03 24338012203 30 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-03) 2017-11-17 0000-00-00 No No Current 24338-122-13 24338012213 100 TABLET, DELAYED RELEASE in 1 BOTTLE (24338-122-13) 2011-04-18 0000-00-00 No No Current